Although an increasing number of patients are diagnosed as PCa at early stages with the introduction of prostate-specific antigen (PSA) screening, approximately 12% of patients still have lymph node invasion (LNI) at initial presentation (1). Here, KLK3 is linked to posterior cortical atrophy.